Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using Midregional Proadrenomedullin (MR-proADM) - Pilot Study

NCT03770533 is registered in ClinicalTrials.gov with Brahms AG as lead sponsor.

NCT NCT03770533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03770533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Patients With Suspicion of Infection in the ED Who Have Low Disease Severity Using Midregional Proadrenomedullin (MR-proADM) - Pilot Study
Lead sponsor
Brahms AG
Phase
Not applicable
Overall status
Completed
Start date
December 14, 2018
Completion date
December 11, 2019
Enrollment
200 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

patients presenting with suspicion of infection to the ed